Lanean...
Cardiotoxicity with vascular endothelial growth factor inhibitor therapy
Angiogenesis inhibitors targeting the vascular endothelial growth factor (VEGF) signaling pathway (VSP) have been important additions in the therapy of various cancers, especially renal cell carcinoma and colorectal cancer. Bevazicumab, the first VSP to receive FDA approval in 2004 targeting all cir...
Gorde:
| Argitaratua izan da: | NPJ Precis Oncol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Nature Publishing Group UK
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5988734/ https://ncbi.nlm.nih.gov/pubmed/30202791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41698-018-0056-z |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|